Background Among patients with a proximal vessel occlusion in the anterior circulation, 60
to 80% of patients die within 90 days after stroke onset or do not regain functional …

Background Nerinetide, an eicosapeptide that interferes with post-synaptic density protein
95, is a neuroprotectant that is effective in preclinical stroke models of ischaemia-reperfusion. …

Background Intravenous thrombolysis with alteplase bolus followed by infusion is a global
standard of care for patients with acute ischaemic stroke. We aimed to determine whether …

We assessed the impact of the coronavirus disease 19 (COVID-19) pandemic on code stroke
activations in the emergency department, stroke unit admissions, and referrals to the stroke …

Background In non-surgical settings, covert stroke is more common than overt stroke and is
associated with cognitive decline. Although overt stroke occurs in less than 1% of adults after …

… Jennifer Mandzia is an advisory board with Bayer; and is clinical trial Site PI for several
studies. Daniel Ngui is a member of the Advisory Board for Amgen, Astra Zeneca, BMS, BI, Lilly, …

Background and Purpose— Minor stroke and transient ischemic attack with an intracranial
occlusion are associated with neurological deterioration and disability. Tenecteplase (TNK–…

Stroke can cause neurological impairment ranging from mild to severe, but the impact of
stroke extends beyond the initial brain injury to include a complex interplay of devastating …

The Canadian Stroke Best Practice Consensus Statement Acute Stroke Management during
Pregnancy is the second of a two-part series devoted to stroke in pregnancy. The first part …

Importance The benefits of endovascular thrombectomy (EVT) are time dependent. Prior
studies may have underestimated the time-benefit association because time of onset is …